Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 38 INDUSTRY 7 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 49 Prostatic Neoplasms 38 Carcinoma, Non-Small-Cell Lung 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Neoplasms 23 Multiple Myeloma 22 Lymphoma 21 Leukemia, Myeloid, Acute 17 Colorectal Neoplasms 17 Melanoma 15 Lung Neoplasms 13 Hodgkin Disease 11 Brain Neoplasms 11 Medulloblastoma 10 Lymphoma, Non-Hodgkin 10 Glioblastoma 10 Squamous Cell Carcinoma of Head and Neck 9 Pancreatic Neoplasms 9 Neoplasm Metastasis 9 Leukemia, Biphenotypic, Acute 9 Leukemia 9 Head and Neck Neoplasms 9 HIV Infections 9 Neuroblastoma 8 Hematologic Neoplasms 8 Ependymoma 8 Glioma 7 Carcinoma, Renal Cell 7 Astrocytoma 7 Wilms Tumor 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × NSCLC × 1 year × Clear all

NCT05714891 2026-02-12

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

Canadian Cancer Trials Group

Phase 2 Active not recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡